Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders" - Reply - Letter to the editor

被引：10
|
作者：
Tollefson, GD [1 ]
Tran, PV [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Clin Res, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1998年 / 18卷 / 02期
关键词：
D O I：
10.1097/00004714-199804000-00016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：177 / 179
页数：3
相关论文
共 50 条
  • [21] Risperidone versus haloperidol for prevention of relapse in schizophrenia and schizoaffective disorders: Long-term double-blind comparison
    Csernansky, J
    Okamoto, A
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 198 - 198
  • [22] A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia
    Pollock, Bruce G.
    Mulsant, Benoit H.
    Rosen, Jules
    Mazumdar, Sati
    Blakesley, Richard E.
    Houck, Patricia R.
    Huber, Kimberly A.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (11): : 942 - 952
  • [23] A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia
    Breier, A
    Keefe, RS
    Young, CA
    Purdon, SE
    Gold, JM
    Davis, KL
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 274 - 275
  • [24] Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
    Zhang, Hongyan
    Li, Huafang
    Shu, Liang
    Gu, Niufan
    Wang, Gang
    Weng, Yongzhen
    Xie, Shiping
    Zhang, Xinbao
    Li, Ting
    Ma, Cui
    Yu, Wei
    Parsons, Bruce
    Schou, Manjula
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 77 - 85
  • [25] A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities
    Fontaine, CS
    Hynan, LS
    Koch, K
    Martin-Cook, K
    Svetlik, D
    Weiner, MF
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (06) : 726 - 730
  • [26] Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double-blind olanzapine trial
    Ishigooka, J
    Inada, T
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) : 403 - 414
  • [27] Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study
    Bondolfi, G
    Dufour, H
    Patris, M
    May, JP
    Billeter, U
    Eap, CB
    Baumann, P
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (04): : 499 - 504
  • [28] A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders
    Svestka, J
    Synek, O
    Zourkova, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S292 - S292
  • [29] A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia
    Osumokun, O.
    Kanc, J. M.
    Kryzhanovskaya, L. A.
    Xu, W.
    Stauffer, V.
    Watson, S. B.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 153 - 153
  • [30] A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia
    Kane, John M.
    Osuntokun, Olawale
    Kryzhanovskaya, Ludmila A.
    Xu, Wen
    Stauffer, Virginia
    Watson, Susan B.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 289S - 289S
12345